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OBJECTIVE
To examine the treatment and management of
non-traumatic hemoptysis in a collegiate
football player.

MEDICAL HISTORY
A 23-year old, 242 pound, 6 foot 2 inch tall
male, Caucasian collegiate football player
(defensive lineman) reported to the Athletic
Training Facility on August 30, 2017 stating
that he noticed blood in his sputum the night
before, as well as experienced sharp back
pain, shortness of breath, left chest pain, and
was tender upon palpation at the eleventh and
twelfth ribs. While obtaining the patient’s
history, he reported no recognition of being
hit in the flank area, rib cage, or being tackled
at practice. The patient denied any known
injury, fever, chills, calf tenderness, and noted
that the chest pain he was experiencing
subsided on the evening of August 30. The
patient’s vitals were within normal limits
while under the care of the emergency
department physician (pulse 76 bpm,
respiratory rate 16 bpm, body temperature
98.9oF), except for a blood pressure of 150/80
mmHg, which was elevated compared to preparticipation readings of 118/82 mmHg. The
patient’s mother stated that several members
of the family have a positive history of deep
vein thrombosis (DVT) and pulmonary emboli
(PE), but the family is unaware of a clotting
disorder. The patient denied a personal
history of DVT or PE, as well as any recent
immobilization, travel, surgery, or trauma
that could have been a precursor to a potential
blood clotting condition. He stated that he has
a negative social history of smoking, drug use,
or alcohol abuse.

DIFFERENTIAL DIAGNOSIS
Spontaneous pneumothorax, bronchitis,
small-cell lung cancer, intercostal muscle
strain, tuberculosis.

RELATED LITERATURE
Hemoptysis can be classified by the amount of
blood lost per day to distinguish between
massive and non-massive hemoptysis.1 An
expectorated blood volume between 100 and
1,000 mL have been used to define massive
hemoptysis, but there is no volume that has
been universally accepted in scientific
literature.1 Literature indicated that up to
42% of hemoptysis cases have no identifiable
cause.1 Over half of the affected population
experiences PE due to factors including family
history of clotting disorders, heart attack,
stroke, trauma, and leading a sedentary
lifestyle.2 In previous research, hemoptysis
has a direct correlation to pulmonary
contusions as a result of direct trauma, such as
those seen in a collegiate football player and
diver.3-4
TREATMENT and MANAGEMENT
The patient’s Athletic Trainers and Team
Physician deemed it necessary to order a
chest x-ray. Due to negative results, the
patient was then instructed to go to the
emergency department, where a computed
tomography (CT) scan was subsequently
requested,
accompanied
by
an
electrocardiogram (ECG) to rule out
additional pathologies. The patient was
treated for bilateral PE, as well as a left lower
lobe pulmonary infarction as confirmed by the
chest CT scan. He was placed on an
anticoagulant medication and admitted to a
local hospital for continued observation.
While in the hospital, he was initially
prescribed Rivaroxaban in 15 mg tablets, to be
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followed with a regimen of 20 mg tablets.
After 48 hours, the patient was released from
the hospital under the care of the Team
Physician at which time ibuprofen and
acetaminophen used for back pain were
discontinued and a strict blood thinner
regimen was implemented. In an effort to aid
in finding a cause for the PE and pulmonary
infarction the Team Physician referred the
patient to a Hematologist to be tested for
Factor V Leiden, as well as the prothrombin
gene. Both genetic tests elicited negative
results. The patient was instructed by the
hematologist to remain on a blood thinner
regimen for six to twelve months. It was
decided that it was in the best interest of the
patient’s long-term health to not return to
competition due to the sudden and ambiguous
symptoms of hemoptysis.

UNIQUENESS
Pertaining to this case, there is limited
research discussing the non-traumatic nature
of hemoptysis. Other unique features to this
case include the patient’s negative genetic
testing for possible clotting factors related to
PE. In most cases, hemoptysis is caused by
predisposing factors, such as stroke, heart
attack, or trauma, none of which the patient
experienced.1 However, it is noted in a recent
case study surrounding a collegiate gymnast
suffering from non-traumatic hemoptysis and
bilateral pulmonary emboli, that the athlete

be placed on anticoagulant therapy and
withdrawn from competition.5

CONCLUSION
Due to the danger of competing in a collision
sport while on a blood thinner regimen for
recovery of idiopathic bilateral PE and
pulmonary infarction, patients should be
withheld from participation based on findings
from previous research.1 The Team Physician,
in collaboration with the patient and his
specialists, decided to medically withdraw the
athlete from contact competition.
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